Location San Francisco Bay Area, California, United States Regions West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Eric Tardif brings to Maravai LifeSciences over 20 years of experience in investment banking, corporate development and strategy, and operations management focusing on medical devices, diagnostics and life sciences. Prior to co-founding Maravai LifeSciences, Mr. Tardif led corporate development and corporate strategy at Gen-Probe. He worked with
Carl Hull to reshape and implement Gen-Probe’s new diagnostics market strategy, in addition to executing acquisitions, divestitures and licensing transactions. He also took on various operating roles overseeing sales, marketing, operations, R&D, quality and regulatory functions. He played a central role in effecting the sale of Gen-Probe to Hologic. Following the transaction, he was promoted to lead corporate strategy for all of Hologic. Mr. Tardif began his career as an investment banker executing mergers and acquisitions for Merrill Lynch, Piper Jaffray and Morgan Stanley. Throughout his banking career, he centered his attention on medical device companies, with a particular focus on the life sciences tools and diagnostics segments. Mr. Tardif has a Master of Science in finance from Boston College, an MBA from University of British Columbia and a B.A. in business administration from Major Bishops University.
